Globus Medical Income from Discontinued Operations 2010-2024 | GMED

Globus Medical annual/quarterly income from discontinued operations history and growth rate from 2010 to 2024. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
  • Globus Medical income from discontinued operations for the quarter ending September 30, 2024 was $M, a NAN% increase year-over-year.
  • Globus Medical income from discontinued operations for the twelve months ending September 30, 2024 was $0M, a NAN% increase year-over-year.
  • Globus Medical annual income from discontinued operations for 2023 was $0B, a NAN% decline from 2022.
  • Globus Medical annual income from discontinued operations for 2022 was $0B, a NAN% decline from 2021.
  • Globus Medical annual income from discontinued operations for 2021 was $0B, a NAN% decline from 2020.
Globus Medical Annual Income from Discontinued Operations
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Globus Medical Quarterly Income from Discontinued Operations
(Millions of US $)
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31 $0
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2009-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $11.562B $1.568B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $197.408B 24.08
Intuitive Surgical (ISRG) United States $196.120B 102.54
Alcon (ALC) Switzerland $42.207B 28.24
Edwards Lifesciences (EW) United States $41.510B 26.36
IQVIA Holdings (IQV) United States $35.864B 19.76
IDEXX Laboratories (IDXX) United States $34.273B 40.36
DexCom (DXCM) United States $29.084B 43.80
Waters (WAT) United States $21.880B 32.35
STERIS (STE) Ireland $21.298B 24.52
SONOVA HOLDING (SONVY) Switzerland $20.458B 0.00
Hologic (HOLX) United States $18.284B 19.29
Fresenius Medical Care AG KGaA (FMS) Germany $12.898B 13.24
Sysmex ADR (SSMXY) Japan $12.776B 40.07
Penumbra (PEN) United States $9.230B 90.41
Masimo (MASI) United States $9.055B 43.81
Teleflex (TFX) United States $8.854B 14.12
Glaukos (GKOS) United States $7.765B 0.00
PROCEPT BioRobotics (PRCT) United States $4.929B 0.00
Integer Holdings (ITGR) United States $4.558B 25.83
Veracyte (VCYT) United States $3.018B 90.56
Inari Medical (NARI) United States $2.913B 0.00
LivaNova (LIVN) United Kingdom $2.807B 16.21
TransMedics (TMDX) United States $2.663B 84.40
Nihon Kohden (NHNKY) Japan $2.428B 18.44
Elekta AB (EKTAY) Sweden $2.125B 17.31
Tandem Diabetes Care (TNDM) United States $2.019B 0.00
RxSight (RXST) United States $1.816B 0.00
Integra LifeSciences Holdings (IART) United States $1.775B 9.27
Alphatec Holdings (ATEC) United States $1.448B 0.00
Artivion (AORT) United States $1.175B 77.86
OPKO Health (OPK) United States $1.065B 0.00
Pulse Biosciences (PLSE) United States $0.992B 0.00
Paragon 28 (FNA) United States $0.873B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.828B 14.08
ORTHOFIX MEDICAL INC (OFIX) United States $0.714B 0.00
IRadimed (IRMD) United States $0.675B 36.46
OrthoPediatrics (KIDS) United States $0.641B 0.00
AxoGen (AXGN) United States $0.577B 0.00
Mesa Laboratories (MLAB) United States $0.548B 12.91
SiBone (SIBN) United States $0.515B 0.00
Treace Medical Concepts (TMCI) United States $0.495B 0.00
Pacific Biosciences Of California (PACB) United States $0.485B 0.00
Semler Scientific (SMLR) United States $0.483B 32.40
Tactile Systems Technology (TCMD) United States $0.383B 20.70
CVRx (CVRX) United States $0.358B 0.00
Delcath Systems (DCTH) United States $0.315B 0.00
ClearPoint Neuro (CLPT) United States $0.306B 0.00
AngioDynamics (ANGO) United States $0.282B 0.00
NeuroPace (NPCE) United States $0.269B 0.00
Inogen (INGN) United States $0.219B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
Accuray (ARAY) United States $0.190B 0.00
KORU Medical Systems (KRMD) United States $0.164B 0.00
Nevro (NVRO) United States $0.163B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Atossa Genetics (ATOS) United States $0.150B 0.00
Sensus Healthcare (SRTS) United States $0.146B 15.67
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
908 Devices (MASS) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
LENSAR (LNSR) United States $0.087B 0.00
WORK Medical Technology Group (WOK) China $0.084B 0.00
Covalon Technologies (CVALF) Canada $0.077B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.067B 0.00
Vicarious Surgical (RBOT) United States $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
EnVVeno Medical (NVNO) United States $0.058B 0.00
Rapid Micro Biosystems (RPID) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.042B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.028B 0.00
Neuronetics (STIM) United States $0.025B 0.00
NexGel (NXGL) United States $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00